James Targett of Citigroup application loan payday,payday loan application1 hour loan payday,payday loan in 1 hour,1 hour payday loanloan till paydayno fax payday cash advancepayday loan best rate,best loan payday,best payday loangeorgia in loan paydayquick payday loanonline payday loan servicecash till payday loanfax loan missouri no paydaymoney tree payday loansavings account payday loanfaxless payday loanadvance […]

Collins Stewart says buy up to 447p after the KPIs.
Analyst Stephen Ford says: ‘At present Playtech trades on a 2008 P/e of 17.6x, broadly the same rating as Party and 888.
Given the consistent delivery of growth from its high quality business model and with 49% EPS growth forecast for 2008, we believe this […]

Big call from Evos analyst Nigel Parson, who says buy and reckons the stock is 30% undervalued.
Not sure whether I agree short term given the chaos created by the smoking ban. If were me, then I’d come back in six months’ time.

Sphere It

The New York French Press deal does nothing to lift Citi analyts Mark Sugarman’s recommendation on the stock. He is still a seller at 26p.

Two failed bids and we are back to square one. Management seemed willing to open the books on both occassions. What does this say about their committment to Sainsbury as a PLC?

Sphere It

Another announcement seems to reinforce what we have said in the past - this is a decent bet on the gold price.

John Pearce at Lehmans has taken on the task of picking the winners and losers in the sector. He says that most risky are the companies with large investment banking operations. He singles out Royal Bank of Scotland as a potential loser.
Winners that offer low risk and reasonably high growth include Standard Chartered, Santander and […]

Numis is bullish on the fundamentals, but admits the share price target needs to come back. It was 600p, although we are putting it under review, as it is likely to come down to somewhere between 475p and 500p, which would equate to 20x Dec 08 EPS (8x Dec 08 EBITDA). ‘

Sphere It

Lehman Brothers has raised its price target 20p to 215p.

Goldman has removed the stock from its conviction buy list; but the stock remains a buy. ‘We believe that better upside opportunity exists in Roche, following its 10% share price fall since October 11, and Merck KGaA in the mid-cap space.
‘Shire has risen 3.1% since being added to the Conviction Buy List on September 17, […]

Lehman has upgraded to overweight with a 425p a share price target.

UBS guru Alan Erskine has raised his price target by 9% to 1930p: ‘Our price target is primarily derived by applying a 5% yield to our estimate of the 3-year movingaverage
free cash flow, to which we add 50p to partly discount the value that we believe portfolio re-shaping would release and 80p to reflect the […]

You may have seen that Fritz Seegers went into the market on Friday and bought almost 400 grand’s worth of stock in the bank.
The reasons for this were two-fold: To shore up confidence in the group and the prove that there is no underlying funding worries. Seegers wouldn’t have been allowed to buy if there […]